Claims for Patent: 7,915,039

Summary for Patent: 7,915,039

Title:	Method for obtaining mesenchymal stem cells
Abstract:	The invention relates to the field of cell biology. In detail it relates to the obtainment of mesenchymal stem cells from human tissue. This invention might be applicable in healing within the frame of the treatment of several diseases. Due to the invention it will be possible to obtain mesenchymal stem cells from human tissue with high homogeneity of the cell suspension, since the used method for obtaining mesenchymal stem cells from human tissue comprises the crushing and enzymatical treatment of the tissue with collagenase solution in Eagle medium in the Dulbecco modification, removal of erythrocytes by the aid of the lysis solution and subsequent filtration of the prepared suspension; as human tissue fat tissue or decidual or amniotic placenta membrane or chorion placenta stroma is used, whereas the filtration is performed sequentially by the use of filters comprising a pore size of 100 .mu.m and 10 .mu.m. In the enzymatical treatment of the fat tissue, of the decidual or amniotic placenta membrane collagenase of the type I is used, and in the enzymatical treatment of the chorion placenta stroma collagenase of the type IV is used.
Inventor(s):	Teplyashin; Alexander S. (Moskau, RU)
Assignee:
Application Number:	11/969,772
Patent Claims:	1. A method for obtaining and/or isolating mesenchymal stem cells from human tissue, comprising the following steps: (a) providing human tissue, wherein the human tissue is fat tissue, placenta tissue, or a combination thereof, (b) enzymatic and mechanical treatment of said human tissue to obtain a cell suspension, (c) removal of erythrocytes from said suspension, and (d) filtration of said suspension for obtaining mesenchymal stem cells, wherein in step (d) said suspension is firstly filtered through a first filter comprising a pore size of 100 .mu.m, and secondly filtered through a second filter comprising a pore size of 10 .mu.m, thereby obtaining and/or isolating mesenchymal stem cells. 2. The method according to claim 1, wherein in step (a) the human tissue is placenta tissue. 3. The method according to claim 1, wherein in step (a) the human tissue is fat tissue. 4. The method according to claim 1, wherein in step (b) for said enzymatic treatment collagenase is used. 5. The method according to claim 1, wherein in step (b) for said enzymatic treatment collagenase of type I is used. 6. The method according to claim 1, wherein in step (b) for said enzymatic treatment collagenase is used, wherein collagenase is provided in Dulbecco's modified Eagle medium. 7. The method according to claim 1, wherein in step (b) for said enzymatic treatment collagenase is used, wherein collagenase is provided in a final concentration of about 0.075%. 8. The method according to claim 1, wherein in step (c) said removal of erythrocytes is performed by the aid of buffer capable of lysing said erythrocytes. 9. A method for obtaining mesenchymal stem cells from human tissue, comprising crushing and enzymatically treating said human tissue with collagenase type I in Dulbecco's modified Eagle medium, wherein said human tissue is fat tissue, placenta tissue or a combination thereof; removing erythrocytes using a lysis solution to prepare a suspension; and filtering the suspension, wherein said filtration comprises filtering the suspension through a filter with a pore size of 100 .mu.m and filtering the suspension through a filter with a pore size of 10 .mu.m; thereby obtaining mesenchymal stem cells. 10. The method according to claim 9, wherein the human tissue is fat tissue or placenta tissue. 11. A method for obtaining and/or isolating mesenchymal stem cells from human tissue, comprising the following steps: (a) providing human tissue, (b) enzymatic and mechanical treatment of said human tissue for obtaining a cell suspension, (c) removing erythrocytes from said cell suspension, and (d) filtering said suspension to obtain purified cells, (e) cultivating the purified cells to obtain mesenchymal stem cells, wherein in step (a) fat tissue or/and placenta tissue is said human tissue, and wherein in step (d) said suspension is firstly filtered through a first filter comprising a pore size of 100 .mu.m, and secondly filtered through a second filter comprising a pore size of 10 .mu.m, thereby obtaining and/or isolating mesenchymal stem cells, and wherein said human tissue is fat tissue, placenta tissue or a combination thereof. 12. The method according to claim 11, wherein in step (a) said human tissue is fat tissue. 13. The method according to claim 11, wherein in step (a) said human tissue is placenta tissue. 14. The method according to claim 11, wherein in step (a) said human tissue is a combination of fat tissue and placenta tissue. 15. The method according to claim 11, wherein step (e) the cultivation is performed for 24 hours. 16. The method of claim 1, wherein the mesenchymal stem cells are negative for CD34 expression. 17. The method of claim 16, wherein the mesenchymal stem cells are negative for CD31, CD45, and CD117 expression. 18. The method of claim 1, wherein the mesenchymal stem cells are positive for CD10, CD13, CD44, CD90 and CD105 expression. 19. The method of claim 1, wherein between 1.5.times.10.sup.4 and 10.sup.7 mesenchymal stem cells are obtained per gram of human tissue.

Details for Patent 7,915,039

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2024-04-09